Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease

D. V. Landers, P. Wolner-Hanssen, J. Paavonen, E. Thorpe, N. Kiviat, M. Ohm-Smith, J. R. Green, J. Schachter, K. K. Holmes, D. A. Eschenbach, Richard L Sweet

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

We compared the clinical and microbiologic efficacy of two broad-spectrum combination antimicrobial regimens in the treatment of 148 patients with acute pelvic inflammatory disease. Patients were randomized to inpatient treatment with either cefoxitin and doxycycline (n = 75) or clindamycin and tobramycin (n = 73). These antibiotics were administered intravenously for at least 4 days, and up to 48 hours beyond defervescence. Patients were discharged on a regimen of oral doxycycline or clindamycin in accordance with the intravenous regimen to complete a total duration of therapy of 2 weeks. Neisseria gonorrhoeae (58%) and Chlamydia trachomatis (31%) were the microorganisms that were isolated most frequently from the genital tract of enrolled patients. At follow-up, N. gonorrhoeae was isolated in two patients, and C. trachomatis was isolated in none. The overall initial favorable response rate to combination antimicrobial therapy was 98.5% (130/132) in patients with uncomplicated pelvic inflammatory disease and 81% (13/16) in patients with pelvic inflammatory disease that was complicated by tuboovarian abscess. A > 70% decrease in abdominal tenderness score occurred in 89% of 111 patients within 6 weeks of hospital discharge. There were no significant differences between antibiotic treatment groups in any response categories or in toxicity. During the initial hospitalization, five patients (three with tuboovarian abscess, one with a pyosalpinx, and one with intractable acute and chronic pelvic inflammatory disease) required surgical intervention. These results support the recommendation to use broad-spectrum combination antimicrobial therapy for the treatment of acute pelvic inflammatory disease.

Original languageEnglish (US)
Pages (from-to)849-858
Number of pages10
JournalAmerican Journal of Obstetrics and Gynecology
Volume164
Issue number3
StatePublished - 1991

Fingerprint

Pelvic Inflammatory Disease
Therapeutics
Clindamycin
Neisseria gonorrhoeae
Doxycycline
Chlamydia trachomatis
Abscess
Anti-Bacterial Agents
Cefoxitin
Tobramycin
Inpatients
Hospitalization

Keywords

  • acute salpingitis
  • pelvic infections
  • pelvic inflammatory disease
  • sexually transmitted diseases

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Landers, D. V., Wolner-Hanssen, P., Paavonen, J., Thorpe, E., Kiviat, N., Ohm-Smith, M., ... Sweet, R. L. (1991). Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology, 164(3), 849-858.

Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. / Landers, D. V.; Wolner-Hanssen, P.; Paavonen, J.; Thorpe, E.; Kiviat, N.; Ohm-Smith, M.; Green, J. R.; Schachter, J.; Holmes, K. K.; Eschenbach, D. A.; Sweet, Richard L.

In: American Journal of Obstetrics and Gynecology, Vol. 164, No. 3, 1991, p. 849-858.

Research output: Contribution to journalArticle

Landers, DV, Wolner-Hanssen, P, Paavonen, J, Thorpe, E, Kiviat, N, Ohm-Smith, M, Green, JR, Schachter, J, Holmes, KK, Eschenbach, DA & Sweet, RL 1991, 'Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease', American Journal of Obstetrics and Gynecology, vol. 164, no. 3, pp. 849-858.
Landers DV, Wolner-Hanssen P, Paavonen J, Thorpe E, Kiviat N, Ohm-Smith M et al. Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology. 1991;164(3):849-858.
Landers, D. V. ; Wolner-Hanssen, P. ; Paavonen, J. ; Thorpe, E. ; Kiviat, N. ; Ohm-Smith, M. ; Green, J. R. ; Schachter, J. ; Holmes, K. K. ; Eschenbach, D. A. ; Sweet, Richard L. / Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. In: American Journal of Obstetrics and Gynecology. 1991 ; Vol. 164, No. 3. pp. 849-858.
@article{1d4e2efa549e452daa47d94a6eaf0223,
title = "Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease",
abstract = "We compared the clinical and microbiologic efficacy of two broad-spectrum combination antimicrobial regimens in the treatment of 148 patients with acute pelvic inflammatory disease. Patients were randomized to inpatient treatment with either cefoxitin and doxycycline (n = 75) or clindamycin and tobramycin (n = 73). These antibiotics were administered intravenously for at least 4 days, and up to 48 hours beyond defervescence. Patients were discharged on a regimen of oral doxycycline or clindamycin in accordance with the intravenous regimen to complete a total duration of therapy of 2 weeks. Neisseria gonorrhoeae (58{\%}) and Chlamydia trachomatis (31{\%}) were the microorganisms that were isolated most frequently from the genital tract of enrolled patients. At follow-up, N. gonorrhoeae was isolated in two patients, and C. trachomatis was isolated in none. The overall initial favorable response rate to combination antimicrobial therapy was 98.5{\%} (130/132) in patients with uncomplicated pelvic inflammatory disease and 81{\%} (13/16) in patients with pelvic inflammatory disease that was complicated by tuboovarian abscess. A > 70{\%} decrease in abdominal tenderness score occurred in 89{\%} of 111 patients within 6 weeks of hospital discharge. There were no significant differences between antibiotic treatment groups in any response categories or in toxicity. During the initial hospitalization, five patients (three with tuboovarian abscess, one with a pyosalpinx, and one with intractable acute and chronic pelvic inflammatory disease) required surgical intervention. These results support the recommendation to use broad-spectrum combination antimicrobial therapy for the treatment of acute pelvic inflammatory disease.",
keywords = "acute salpingitis, pelvic infections, pelvic inflammatory disease, sexually transmitted diseases",
author = "Landers, {D. V.} and P. Wolner-Hanssen and J. Paavonen and E. Thorpe and N. Kiviat and M. Ohm-Smith and Green, {J. R.} and J. Schachter and Holmes, {K. K.} and Eschenbach, {D. A.} and Sweet, {Richard L}",
year = "1991",
language = "English (US)",
volume = "164",
pages = "849--858",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease

AU - Landers, D. V.

AU - Wolner-Hanssen, P.

AU - Paavonen, J.

AU - Thorpe, E.

AU - Kiviat, N.

AU - Ohm-Smith, M.

AU - Green, J. R.

AU - Schachter, J.

AU - Holmes, K. K.

AU - Eschenbach, D. A.

AU - Sweet, Richard L

PY - 1991

Y1 - 1991

N2 - We compared the clinical and microbiologic efficacy of two broad-spectrum combination antimicrobial regimens in the treatment of 148 patients with acute pelvic inflammatory disease. Patients were randomized to inpatient treatment with either cefoxitin and doxycycline (n = 75) or clindamycin and tobramycin (n = 73). These antibiotics were administered intravenously for at least 4 days, and up to 48 hours beyond defervescence. Patients were discharged on a regimen of oral doxycycline or clindamycin in accordance with the intravenous regimen to complete a total duration of therapy of 2 weeks. Neisseria gonorrhoeae (58%) and Chlamydia trachomatis (31%) were the microorganisms that were isolated most frequently from the genital tract of enrolled patients. At follow-up, N. gonorrhoeae was isolated in two patients, and C. trachomatis was isolated in none. The overall initial favorable response rate to combination antimicrobial therapy was 98.5% (130/132) in patients with uncomplicated pelvic inflammatory disease and 81% (13/16) in patients with pelvic inflammatory disease that was complicated by tuboovarian abscess. A > 70% decrease in abdominal tenderness score occurred in 89% of 111 patients within 6 weeks of hospital discharge. There were no significant differences between antibiotic treatment groups in any response categories or in toxicity. During the initial hospitalization, five patients (three with tuboovarian abscess, one with a pyosalpinx, and one with intractable acute and chronic pelvic inflammatory disease) required surgical intervention. These results support the recommendation to use broad-spectrum combination antimicrobial therapy for the treatment of acute pelvic inflammatory disease.

AB - We compared the clinical and microbiologic efficacy of two broad-spectrum combination antimicrobial regimens in the treatment of 148 patients with acute pelvic inflammatory disease. Patients were randomized to inpatient treatment with either cefoxitin and doxycycline (n = 75) or clindamycin and tobramycin (n = 73). These antibiotics were administered intravenously for at least 4 days, and up to 48 hours beyond defervescence. Patients were discharged on a regimen of oral doxycycline or clindamycin in accordance with the intravenous regimen to complete a total duration of therapy of 2 weeks. Neisseria gonorrhoeae (58%) and Chlamydia trachomatis (31%) were the microorganisms that were isolated most frequently from the genital tract of enrolled patients. At follow-up, N. gonorrhoeae was isolated in two patients, and C. trachomatis was isolated in none. The overall initial favorable response rate to combination antimicrobial therapy was 98.5% (130/132) in patients with uncomplicated pelvic inflammatory disease and 81% (13/16) in patients with pelvic inflammatory disease that was complicated by tuboovarian abscess. A > 70% decrease in abdominal tenderness score occurred in 89% of 111 patients within 6 weeks of hospital discharge. There were no significant differences between antibiotic treatment groups in any response categories or in toxicity. During the initial hospitalization, five patients (three with tuboovarian abscess, one with a pyosalpinx, and one with intractable acute and chronic pelvic inflammatory disease) required surgical intervention. These results support the recommendation to use broad-spectrum combination antimicrobial therapy for the treatment of acute pelvic inflammatory disease.

KW - acute salpingitis

KW - pelvic infections

KW - pelvic inflammatory disease

KW - sexually transmitted diseases

UR - http://www.scopus.com/inward/record.url?scp=0026069113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026069113&partnerID=8YFLogxK

M3 - Article

C2 - 1900663

AN - SCOPUS:0026069113

VL - 164

SP - 849

EP - 858

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -